Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients
- 4 November 2003
- journal article
- website
- Published by Wiley in Clinical Transplantation
- Vol. 17 (6) , 546-548
- https://doi.org/10.1046/j.1399-0012.2003.00107.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparison of Trough, 2-Hour, and Limited AUC Blood Sampling for Monitoring Cyclosporin (Neoral®) at Day 7 Post–Renal Transplantation and Incidence of Rejection in the First MonthTherapeutic Drug Monitoring, 2002
- Clinical validation studies of neoral C2 monitoring: a reviewTransplantation, 2002
- Patient management by Neoral C2 monitoring: An international consensus statement1Transplantation, 2002
- Recommendations for the Implementation of Neoral C2 Monitoring in Clinical PracticeTransplantation, 2002
- Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)1Transplantation, 2002
- Optimization of cyclosporine exposure utilizing C2 level monitoring in de novo renal transplant recipients: the toronto general hospital experienceTransplantation Proceedings, 2001
- Single-center study utilizing C2 level as monitoring tool in de novo renal transplant recipients treated with neoralTransplantation Proceedings, 2001
- ABSORPTION PROFILING OF CYCLOSPORINE MICROEMULSION (NEORAL) DURING THE FIRST 2 WEEKS AFTER RENAL TRANSPLANTATION1Transplantation, 2001
- Approaching the Therapeutic Window for Cyclosporine in Kidney TransplantationJournal of the American Society of Nephrology, 2001
- C2 Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral??* FormulationBioDrugs, 2001